343 related articles for article (PubMed ID: 18326623)
41. Genome-wide association study of schizophrenia in Ashkenazi Jews.
Goes FS; McGrath J; Avramopoulos D; Wolyniec P; Pirooznia M; Ruczinski I; Nestadt G; Kenny EE; Vacic V; Peters I; Lencz T; Darvasi A; Mulle JG; Warren ST; Pulver AE
Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):649-59. PubMed ID: 26198764
[TBL] [Abstract][Full Text] [Related]
42. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.
Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG
Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957
[TBL] [Abstract][Full Text] [Related]
43. Investigation of reported associations between the 20q13 and 21q22 loci and pediatric-onset Crohn's disease in Canadian children.
Amre DK; Mack DR; Morgan K; Fujiwara M; Israel D; Deslandres C; Seidman EG; Lambrette P; Costea I; Krupoves A; Fegury H; Dong J; Grimard G; Levy E
Am J Gastroenterol; 2009 Nov; 104(11):2824-8. PubMed ID: 19623168
[TBL] [Abstract][Full Text] [Related]
44. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
45. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
[TBL] [Abstract][Full Text] [Related]
46. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Klaes R; Chen B; Butkiewicz D; Pamula J; Pekala W; Försti A
Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
[TBL] [Abstract][Full Text] [Related]
47. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
Hunter DJ; Kraft P; Jacobs KB; Cox DG; Yeager M; Hankinson SE; Wacholder S; Wang Z; Welch R; Hutchinson A; Wang J; Yu K; Chatterjee N; Orr N; Willett WC; Colditz GA; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Calle EE; Thun MJ; Hayes RB; Tucker M; Gerhard DS; Fraumeni JF; Hoover RN; Thomas G; Chanock SJ
Nat Genet; 2007 Jul; 39(7):870-4. PubMed ID: 17529973
[TBL] [Abstract][Full Text] [Related]
48. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
[TBL] [Abstract][Full Text] [Related]
49. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
50. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
51. Genome-Wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk.
Wang F; Moon W; Letsou W; Sapkota Y; Wang Z; Im C; Baedke JL; Robison L; Yasui Y
Cancer Res; 2023 Jan; 83(2):332-345. PubMed ID: 36354368
[TBL] [Abstract][Full Text] [Related]
52. Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer.
Liu P; Vikis HG; Lu Y; Wang Y; Schwartz AG; Pinney SM; Yang P; de Andrade M; Gazdar A; Gaba C; Mandal D; Lee J; Kupert E; Seminara D; Minna J; Bailey-Wilson JE; Amos CI; Anderson MW; You M
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):517-24. PubMed ID: 20142248
[TBL] [Abstract][Full Text] [Related]
53. Common variants at 6q22 and 17q21 are associated with intracranial volume.
Ikram MA; Fornage M; Smith AV; Seshadri S; Schmidt R; Debette S; Vrooman HA; Sigurdsson S; Ropele S; Taal HR; Mook-Kanamori DO; Coker LH; Longstreth WT; Niessen WJ; DeStefano AL; Beiser A; Zijdenbos AP; Struchalin M; Jack CR; Rivadeneira F; Uitterlinden AG; Knopman DS; Hartikainen AL; Pennell CE; Thiering E; Steegers EA; Hakonarson H; Heinrich J; Palmer LJ; Jarvelin MR; McCarthy MI; Grant SF; St Pourcain B; Timpson NJ; Smith GD; Sovio U; ; Nalls MA; Au R; Hofman A; Gudnason H; van der Lugt A; Harris TB; Meeks WM; Vernooij MW; van Buchem MA; Catellier D; Jaddoe VW; Gudnason V; Windham BG; Wolf PA; van Duijn CM; Mosley TH; Schmidt H; Launer LJ; Breteler MM; DeCarli C;
Nat Genet; 2012 Apr; 44(5):539-44. PubMed ID: 22504418
[TBL] [Abstract][Full Text] [Related]
54. A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31.
Barnekow E; Hasslow J; Liu W; Bryant P; Thutkawkorapin J; Wendt C; Czene K; Hall P; Margolin S; Lindblom A
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901898
[TBL] [Abstract][Full Text] [Related]
55. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Ahmed S; Thomas G; Ghoussaini M; Healey CS; Humphreys MK; Platte R; Morrison J; Maranian M; Pooley KA; Luben R; Eccles D; Evans DG; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Stratton MR; Rahman N; Jacobs K; Prentice R; Anderson GL; Rajkovic A; Curb JD; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Calle EE; Thun MJ; Diver WR; Bojesen S; Nordestgaard BG; Flyger H; Dörk T; Schürmann P; Hillemanns P; Karstens JH; Bogdanova NV; Antonenkova NN; Zalutsky IV; Bermisheva M; Fedorova S; Khusnutdinova E; ; Kang D; Yoo KY; Noh DY; Ahn SH; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Garcia-Closas M; Lissowska J; Brinton L; Peplonska B; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Hopper JL; Southey MC; Smith L; Spurdle AB; Schmidt MK; Broeks A; van Hien RR; Cornelissen S; Milne RL; Ribas G; González-Neira A; Benitez J; Schmutzler RK; Burwinkel B; Bartram CR; Meindl A; Brauch H; Justenhoven C; Hamann U; ; Chang-Claude J; Hein R; Wang-Gohrke S; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Kataja V; Olson JE; Wang X; Fredericksen Z; Giles GG; Severi G; Baglietto L; English DR; Hankinson SE; Cox DG; Kraft P; Vatten LJ; Hveem K; Kumle M; Sigurdson A; Doody M; Bhatti P; Alexander BH; Hooning MJ; van den Ouweland AM; Oldenburg RA; Schutte M; Hall P; Czene K; Liu J; Li Y; Cox A; Elliott G; Brock I; Reed MW; Shen CY; Yu JC; Hsu GC; Chen ST; Anton-Culver H; Ziogas A; Andrulis IL; Knight JA; ; ; Beesley J; Goode EL; Couch F; Chenevix-Trench G; Hoover RN; Ponder BA; Hunter DJ; Pharoah PD; Dunning AM; Chanock SJ; Easton DF
Nat Genet; 2009 May; 41(5):585-90. PubMed ID: 19330027
[TBL] [Abstract][Full Text] [Related]
56. Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer.
Scannell Bryan M; Argos M; Andrulis IL; Hopper JL; Chang-Claude J; Malone KE; John EM; Gammon MD; Daly MB; Terry MB; Buys SS; Huo D; Olopade OI; Genkinger JM; Whittemore AS; Jasmine F; Kibriya MG; Chen LS; Ahsan H
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1057-1064. PubMed ID: 29898891
[No Abstract] [Full Text] [Related]
57. A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population.
Streicher SA; Klein AP; Olson SH; Kurtz RC; Amundadottir LT; DeWan AT; Zhao H; Risch HA
Hum Genet; 2021 Feb; 140(2):309-319. PubMed ID: 32671597
[TBL] [Abstract][Full Text] [Related]
58. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
Meyer KB; Maia AT; O'Reilly M; Teschendorff AE; Chin SF; Caldas C; Ponder BA
PLoS Biol; 2008 May; 6(5):e108. PubMed ID: 18462018
[TBL] [Abstract][Full Text] [Related]
59. Fine mapping of 14q24.1 breast cancer susceptibility locus.
Lee P; Fu YP; Figueroa JD; Prokunina-Olsson L; Gonzalez-Bosquet J; Kraft P; Wang Z; Jacobs KB; Yeager M; Horner MJ; Hankinson SE; Hutchinson A; Chatterjee N; Garcia-Closas M; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Thun MJ; Diver R; Prentice R; Jackson R; Kooperberg C; Chlebowski R; Lissowska J; Peplonska B; Brinton LA; Tucker M; Fraumeni JF; Hoover RN; Thomas G; Hunter DJ; Chanock SJ
Hum Genet; 2012 Mar; 131(3):479-90. PubMed ID: 21959381
[TBL] [Abstract][Full Text] [Related]
60. A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16.
Barnekow E; Liu W; Helgadottir HT; Michailidou K; Dennis J; Bryant P; Thutkawkorapin J; Wendt C; Czene K; Hall P; Margolin S; Lindblom A
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
